About article

Validity and reliability of the arabic version of the National Institutes of Health Chronic Prostatitis Symptom Index



Article type: Published article

Abstract

INTRODUCTION: In order to accurately assess the extent of chronic pelvic pain syndrome (CPPS) and to objectively measure symptoms for natural history studies and to assess the outcome parameters for clinical trials, the National Institutes of Health (NIH) Chronic Prostatitis Collaborative Research Network developed and validated the NIH Chronic Prostatitis Symptom Index (NIH-CPSI). The aim of the current study was to develop and validate a fluent and comprehensive Arabic version of the NIH-CPSI. METHODS: This study consisted of 80 consecutive male patients affected by CPPS and 80 healthy controls who were asked to complete the Arabic version of the NIH-CPSI. The translation was performed by a group consisting of an andrologist and professional translators. Psychometric data were collected. RESULTS: Of the 160 subjects enrolled, 82 (50 patients and 32 controls) completed the study. The total Arabic NIH-CPSI scores and the scores of each subscale differed significantly between the two groups with good discriminant validity. The questionnaire had also a high internal consistency. CONCLUSION: The present study provides the Arabic version of the NIH-CPSI and recognizes it as a valid and reliable tool in the assessment of local patients with CPPS.


Full citation

El-Nashaar A, Fathy A, Zeedan A, Al-Ahwany A, Shamloul R. Validity and reliability of the arabic version of the National Institutes of Health Chronic Prostatitis Symptom Index. Urol Int. 2006;77(3):227-31.


Methodology

Methods Condition Gender Age Country Setting Sample size
chronic pelvic pain syndrome patents and controls Both Egypt
160

Number of items

9 items

Training

Measure does not require training

Required time

6-30 min






© 2019 | Privacy Policy
All Rights Reserved

Notify me for new AHM projects / news


Contact Us
hsrc-ahm@pnu.edu.sa

Articles last updated: March 2020